GET /trials/source/12/
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 434,
    "next": "http://api.gregory-ms.com/trials/source/12/?page=2",
    "previous": null,
    "results": [
        {
            "title": "Kinesiotape on Balance in With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Individuals With Multiple Sclerosis;   With Ataxia Symptoms;   No Secondary Disease Affecting Balance<br /><b>Intervention</b>:    Other: Kinesiotape<br /><b>Sponsor</b>:    Firat University<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05341895?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-22T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-22T12:30:07.386002Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Functional Outcomes From Diets in Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Relapsing Remitting Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis<br /><b>Interventions</b>:    Behavioral: Glycemic load;   Behavioral: Calorie restriction;   Behavioral: Behavioral support<br /><b>Sponsors</b>:    University of Alabama at Birmingham;   Washington University School of Medicine;   United States Department of Defense<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05327322?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-14T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-14T10:59:17.162522Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis, Relapsing-Remitting;   Adult ALL;   Vitamin D3 Deficiency<br /><b>Interventions</b>:    Dietary Supplement: 25(OH)D3;   Dietary Supplement: vitamin D3<br /><b>Sponsors</b>:    Tehran University of Medical Sciences;   Boston University<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05340985?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-22T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-22T12:30:07.387904Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Intervention</b>:    Other: Ofatumumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05776888?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-03-20T12:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-03-20T17:40:48.910361Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": [
                {
                    "category_id": 39,
                    "category_description": "ofatumumab, Kesimpta",
                    "category_name": "ofatumumab",
                    "category_slug": "ofatumumab",
                    "category_terms": [
                        "ofatumumab",
                        "kesimpta"
                    ]
                }
            ]
        },
        {
            "title": "Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Primary Progressive Multiple Sclerosis;   Secondary-progressive Multiple Sclerosis<br /><b>Interventions</b>:    Drug: Metformin Hydrochloride 850 mg Oral Tablet;   Drug: Placebo<br /><b>Sponsors</b>:    University Hospital, Antwerp;   University Hospital, Ghent;   Hasselt University;   AZ Sint-Jan AV;   Noorderhart Pelt;   National MS Center Melsbroek<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05893225?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-06-07T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-06-07T12:50:42.279113Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": [
                {
                    "category_id": 6,
                    "category_description": "",
                    "category_name": "Metformin",
                    "category_slug": "metformin",
                    "category_terms": [
                        "metformin"
                    ]
                }
            ]
        },
        {
            "title": "MS Fatigue and tDCS on Fatigue in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Fatigue in Multiple Sclerosis<br /><b>Interventions</b>:    Procedure: Real left prefrontal tDCS - sham;   Procedure: Sham - Real left prefrontal tDCS<br /><b>Sponsor</b>:    Assistance Publique - Hôpitaux de Paris<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05890885?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-06-06T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-06-06T12:50:42.940754Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Examining a Wheelchair Exercise-training Intervention for Persons With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Interventions</b>:    Behavioral: Seated Physical activity INtervention for persons with MS, \"SPIN\" program- Intervention Condition;   Behavioral: Wellness for MS (WellMS)- Control Condition<br /><b>Sponsors</b>:    University of North Texas, Denton, TX;   University of Illinois at Chicago;   Craig Hospital;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05888727?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-06-05T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-06-05T13:30:45.596685Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Muscle Vibration and Fatigue in Patients With MS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Device: vibra plus<br /><b>Sponsor</b>:    IRCCS Centro Neurolesi \"Bonino-Pulejo\"<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05783999?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-03-24T12:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-04-07T12:40:54.269411Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        },
        {
            "title": "Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study",
            "summary": "<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Intervention</b>:    Other: Ofatumumab<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05809986?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-04-12T12:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-04-12T13:20:45.801420Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": [
                {
                    "category_id": 39,
                    "category_description": "ofatumumab, Kesimpta",
                    "category_name": "ofatumumab",
                    "category_slug": "ofatumumab",
                    "category_terms": [
                        "ofatumumab",
                        "kesimpta"
                    ]
                }
            ]
        },
        {
            "title": "Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Fatigue<br /><b>Interventions</b>:    Device: Transcranial Magnetic Stimulation;   Drug: Amantadine Hydrochloride 100 mg (milligrams) Oral Capsule<br /><b>Sponsor</b>:    Hospital San Carlos, Madrid<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05809414?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2023-04-12T12:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2023-04-12T13:20:45.814266Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null,
            "categories": []
        }
    ]
}